Spacer
Spacer
Login to your account:
Login
Password
  Forgotten password
Spacer
Spacer
USA Map
Spacer
Left top
Spacer 2011 Competition Spacer
Left top
 
Left top
Spacer Signup Spacer
Left top
Spacer
 
Spacer
Spacer
Spacer
Spacer
Spacer
Where am I? > Home
Help Help
Line

US Clinical Researcher Competition

"Recognizing and rewarding excellence in Clinical Research"

This year's winners
Sign Up
 

The US Clinical Researcher Competition

The "US Clinical Researcher Competition " is the only competition which recognizes that special mix of technical and interpersonal skills necessary to be a successful Clinical Researcher.

Entry to the 2011 competition opens soon, why not register your interest now?

Register your interest

To start the process you will need to complete an entry form with your details. Then you will receive a Multiple Choice Questionnaire (MCQ) to answer. If you are successful with this first challenge you will then go on to Stage 2 & possibly 3 and who knows, all the way through to winning!

Winners of each category not only receive the Pharma Award, which is presented on stage at the Awards ceremony, but are also featured on the PharmaTimes US Clinical Researcher website and win a check for 1000 US Dollars too!

 

Latest News Headlines - Friday, July 30, 2010

AstraZeneca shares are on the rise this morning after the firm posted a strong set of financials for the second quarter and celebrated a recommendation for approval from US advisory panel for its bloodthinner Brilinta

Sanofi-Aventis has posted a solid set of figures for the second quarter this morning, but has lowered its full-year earnings forecast due to the introduction this week of generic Lovenox in the USA.

Bayer has posted a 1.3% dip in net income for the second quarter to 525 million euros this morning, but the Leverkusen-based firm’s turnover climbed 14.6% to 9.18 billion euros

Allowing American patients to use EU-approved medicines would increase regulatory competition, enable more patient choice and potentially save the lives of those suffering life-threatening illnesses who currently have no treatment options, says a new study.

Clinical News


Spacer Spacer
Spacer
Sponsors
dashes

I3

dashes

Kendle

dashes

Johnson & Johnson

dashes

AstraZeneca

dashes

GSK

dashes

Johnson & Johnson

dashes

Parexel

dashes



Spacer
Spacer Border
Spacer
Spacer Home | About | Competition categories | Key dates | Enter | Nominate a Colleague | Who leads the competition? | Why should my company get involved? | Attend
Competition outside the Americas
| Who is PharmaTimes?

Contact | FAQ | Terms & Conditions | Privacy Policy | Design by DJM